The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Gemcitabine and cisplatin chemotherapy plus penpulimab combined with or without anlotinib as neoadjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: A prospective, phase II clinical trial.
 
Hai-Qiang Mai
No Relationships to Disclose
 
Xue-Song Sun
No Relationships to Disclose
 
Li-Ting Liu
No Relationships to Disclose
 
Shan-Shan Guo
No Relationships to Disclose
 
Sai Lan Liu
No Relationships to Disclose
 
Xiao-Yun Li
No Relationships to Disclose
 
Yi-Fu Li
No Relationships to Disclose
 
Dongxiang Wen
No Relationships to Disclose
 
Hao-Xiang Long
No Relationships to Disclose
 
Qiu-Yan Chen
No Relationships to Disclose
 
Lin-Quan Tang
No Relationships to Disclose